- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01974401
Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia
Effect of Using Supragingival Irrigators Containing Chlorhexidine on Oral Health in Patients With Blood Dyscrasia
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Khorasan Razavi
-
Mashhad, Khorasan Razavi, Iran, Islamic Republic of
- Oral Medicine Department of Mashhad dental School,Oral and Maxillofacial diseases research center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
patients with a blood dyscrasia, severe neutropenia and thrombocytopenia, absence of periodontitis, absence of any oral mucosal lesion in onset of study, patient consent
Exclusion Criteria:
diabetes mellitus, observation of any side effect (resulted from the device), severe oral mucositis in intervention group(grade 3 and4 WHO), edentulousness, intolerance of device in severely malaise patients, patient death
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: water jet irrigator
patients used supra-gingival irrigators as an oral health measure
|
patients received irrigation by oxyjet supra gingival irrigators containing chlorhexidine for at least 3 minutes for all dentulous regions of jaws which was performed by researchers once daily.
Other Names:
|
|
No Intervention: control group
patients in this group received routine oral health care protocols.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
improvement in oral health status
Time Frame: 3 weeks
|
improvement of oral health was measured by oral health index simplified(OHI-S)
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
incidence of oral mucositis
Time Frame: 3 weeks
|
incidence of mucositis due to Who criteria explored by clinical examination
|
3 weeks
|
Collaborators and Investigators
Investigators
- Study Director: Pegah Mosannen Mozafari, assistant professor, Oral and maxilloifacial diseases research center of Mashhad university of medical sciences
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 89462
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thrombocytopenia
-
Fondazione IRCCS Policlinico San Matteo di PaviaActive, not recruitingThrombocytopenia, Isolated | Thrombocytopenia 4 | CYCS MUTATION- ASSOCIATED THROMBOCYTOPENIA THC4Italy
-
Weill Medical College of Cornell UniversityColumbia University; New York Presbyterian HospitalCompletedAlloimmune Thrombocytopenia | Fetal Alloimmune ThrombocytopeniaUnited States
-
Sylvia ElzekUnknownThrombocytopenia Neonatal
-
Central Hospital, Nancy, FranceRecruitingHeparin-induced ThrombocytopeniaFrance
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingHeparin-induced Thrombocytopenia
-
Veralox TherapeuticsCelerionCompletedHeparin-induced ThrombocytopeniaUnited States
-
Aspen Global IncorporatedTerminatedHeparin-induced ThrombocytopeniaUnited States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
-
Marshall UniversityUnknownHeparin-induced ThrombocytopeniaUnited States
-
Napolitano MariasantaRegione SiciliaTerminatedThrombocytopenia | Primary Thrombocytopenia,Unspecified | Thrombocytopenia Chemotherapy InducedItaly
-
Ottawa Hospital Research InstituteUnknownHeparin-induced Thrombocytopenia (HIT)Canada
Clinical Trials on supragingival irrigators containing chlorhexidine
-
Instituto de Oftalmología Fundación Conde de ValencianaCompleted
-
University of SienaCompletedPeriodontitis | Gingivitis | Chlorhexidine | Cetylpyridinium ChlorideItaly
-
Johnson & Johnson Consumer and Personal Products...CompletedGingivitisUnited Kingdom
-
Second Affiliated Hospital, School of Medicine,...Not yet recruiting
-
Catholic University of the Sacred Heart3M; Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, ItalyUnknownInfection | CatheterizationItaly
-
Johnson & Johnson Consumer Inc. (J&JCI)Withdrawn
-
TC Erciyes UniversityCompleted
-
Chulalongkorn UniversityUnknownWound | Disorder of Skin Donor SiteThailand
-
Dr Meru SCompletedOral Hygiene | pH | Saliva Altered | Tooth Structure; DisorderIndia
-
Dr Meru SCompletedOral Hygiene | pH | Saliva Altered | Tooth Structure; DisorderIndia